BACKGROUND To clarify various conditions in the transplanted kidney, invasive biopsy must be performed in most cases. In this study, we measured blood flow in the transplanted kidney by color Doppler tomography to examine the usefulness of measuring renal blood flow in clarifying various conditions. METHOD Blood flow in the transplanted kidney was measured using peak flow velocity (PFV) and a...

Induction therapy with antilymphocyte biological agents is widely used after kidney transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte globulin (rATG) or an IL-2 receptor antagonist (IL2RA). Early randomized trials showed that rATG or IL2RA induction reduces early acute rejection, prompting recommendations by Kidney Disease Improving Global Outcomes that IL2RA in...

BACKGROUND AND OBJECTIVES In living-donor kidney transplantation, various donor factors, including gender, age, and baseline kidney function, predict allograft function and recipient outcomes after transplantation. Because higher phosphorus is predictive of vascular injury in healthy adults, the effect of donor phosphorus levels on recipient renal function after transplantation was investigated...

A literature review on immune monitoring in kidney transplantation produced dozens of research articles and a multitude of promising biomarkers, all in the quest for the much sought after - but perennially elusive - "holy grail" of kidney biomarkers able to unequivocally predict acute transplant rejection vs non-rejection. Detection methodologies and study designs were many and varied. Hence th...

HUMORAL rejection is a rare but potentially fatal form of acute allograft rejection. Pathophysiologically, allosensitization against graft determinants occurs either preor posttransplantation. Preformed antibodies lead to the phenomenon of hyperacute rejection. The de novo synthesized antibodies directed against HLA antigens expressed on graft endothelium are clearly associated with humoral rej...

Microarray technology is a powerful tool in the discovery of new biomarkers for disease. After solid organ transplantation, where the detection of rejection is usually made on invasive biopsies, it could be hypothesized that noninvasive transcriptional profiling of peripheral blood will reveal rejection-specific expression patterns from circulating immune cells. However, in kidney transplant re...

Kidney transplantation is an effective final therapeutic procedure for patients with end-stage kidney failure. Although advanced immunosuppressive therapy is administered following transplantation, certain patients still suffer from acute allograft rejection. MicroRNAs (miRs) have a potential diagnostic and therapeutic value for acute renal allograft rejection; however, their underlying mechani...

Immunoperoxidase staining was carried out using monoclonal antibody against endothelin-1 on renal allograft biopsy specimens from thirty one patients with acute renal transplant rejection: Banff 97 score IA (n = 11), score IB (n = 10) and score IIA (n = 10). As a control 10 biopsy specimens of the kidneys removed because of trauma were used. Endothelin-1 immunostaining was investigated in the r...

BACKGROUND Acute kidney allograft rejection is a major cause for declining graft function and has a negative impact on the long-term graft survival. The majority (90%) of acute rejections are T-cell mediated and, therefore, the anti-rejection therapy targets T-cell-mediated mechanisms of the rejection process. However, there is increasing evidence that intragraft B-cells are also important in t...

The nitroblue tetrazolium (NBT) test has been evaluated as a means of differentiating episodes of infection and rejection in 10 cadaver kidney transplant recipients. Normal NBT values were observed during all 11 episodes of acute rejection. A significant elevation of the NBT score was encountered in six of eight episodes of infection after transplantation. A positive NBT result is useful additi...